198 related articles for article (PubMed ID: 20972812)
1. The cross-talk between the urokinase receptor and fMLP receptors regulates the activity of the CXCR4 chemokine receptor.
Montuori N; Bifulco K; Carriero MV; La Penna C; Visconte V; Alfano D; Pesapane A; Rossi FW; Salzano S; Rossi G; Ragno P
Cell Mol Life Sci; 2011 Jul; 68(14):2453-67. PubMed ID: 20972812
[TBL] [Abstract][Full Text] [Related]
2. The urokinase receptor takes control of cell migration by recruiting integrins and FPR1 on the cell surface.
Gorrasi A; Li Santi A; Amodio G; Alfano D; Remondelli P; Montuori N; Ragno P
PLoS One; 2014; 9(1):e86352. PubMed ID: 24466048
[TBL] [Abstract][Full Text] [Related]
3. Urokinase receptor and CXCR4 are regulated by common microRNAs in leukaemia cells.
Alfano D; Gorrasi A; Li Santi A; Ricci P; Montuori N; Selleri C; Ragno P
J Cell Mol Med; 2015 Sep; 19(9):2262-72. PubMed ID: 26082201
[TBL] [Abstract][Full Text] [Related]
4. uPAR regulates pericellular proteolysis through a mechanism involving integrins and fMLF-receptors.
Montuori N; Cosimato V; Rinaldi L; Rea VE; Alfano D; Ragno P
Thromb Haemost; 2013 Feb; 109(2):309-18. PubMed ID: 23238745
[TBL] [Abstract][Full Text] [Related]
5. Cross-talk between fMLP and vitronectin receptors triggered by urokinase receptor-derived SRSRY peptide.
Gargiulo L; Longanesi-Cattani I; Bifulco K; Franco P; Raiola R; Campiglia P; Grieco P; Peluso G; Stoppelli MP; Carriero MV
J Biol Chem; 2005 Jul; 280(26):25225-32. PubMed ID: 15866865
[TBL] [Abstract][Full Text] [Related]
6. Urokinase-type plasminogen activator receptor (uPAR) ligation induces a raft-localized integrin signaling switch that mediates the hypermotile phenotype of fibrotic fibroblasts.
Grove LM; Southern BD; Jin TH; White KE; Paruchuri S; Harel E; Wei Y; Rahaman SO; Gladson CL; Ding Q; Craik CS; Chapman HA; Olman MA
J Biol Chem; 2014 May; 289(18):12791-804. PubMed ID: 24644284
[TBL] [Abstract][Full Text] [Related]
7. Single amino acid substitutions in the chemotactic sequence of urokinase receptor modulate cell migration and invasion.
Bifulco K; Longanesi-Cattani I; Franco P; Pavone V; Mugione P; Di Carluccio G; Masucci MT; Arra C; Pirozzi G; Stoppelli MP; Carriero MV
PLoS One; 2012; 7(9):e44806. PubMed ID: 23049759
[TBL] [Abstract][Full Text] [Related]
8. New Pieces in the Puzzle of uPAR Role in Cell Migration Mechanisms.
Gorrasi A; Petrone AM; Li Santi A; Alfieri M; Montuori N; Ragno P
Cells; 2020 Nov; 9(12):. PubMed ID: 33255171
[TBL] [Abstract][Full Text] [Related]
9. The interaction between uPAR and vitronectin triggers ligand-independent adhesion signalling by integrins.
Ferraris GM; Schulte C; Buttiglione V; De Lorenzi V; Piontini A; Galluzzi M; Podestà A; Madsen CD; Sidenius N
EMBO J; 2014 Nov; 33(21):2458-72. PubMed ID: 25168639
[TBL] [Abstract][Full Text] [Related]
10. A new class of orthosteric uPAR·uPA small-molecule antagonists are allosteric inhibitors of the uPAR·vitronectin interaction.
Liu D; Zhou D; Wang B; Knabe WE; Meroueh SO
ACS Chem Biol; 2015 Jun; 10(6):1521-34. PubMed ID: 25671694
[TBL] [Abstract][Full Text] [Related]
11. VEGF-induced endothelial cell migration requires urokinase receptor (uPAR)-dependent integrin redistribution.
Alexander RA; Prager GW; Mihaly-Bison J; Uhrin P; Sunzenauer S; Binder BR; Schütz GJ; Freissmuth M; Breuss JM
Cardiovasc Res; 2012 Apr; 94(1):125-35. PubMed ID: 22287577
[TBL] [Abstract][Full Text] [Related]
12. Deacetylated GM3 promotes uPAR-associated membrane molecular complex to activate p38 MAPK in metastatic melanoma.
Yan Q; Bach DQ; Gatla N; Sun P; Liu JW; Lu JY; Paller AS; Wang XQ
Mol Cancer Res; 2013 Jun; 11(6):665-75. PubMed ID: 23525268
[TBL] [Abstract][Full Text] [Related]
13. Incorporation of CXCR4 into membrane lipid rafts primes homing-related responses of hematopoietic stem/progenitor cells to an SDF-1 gradient.
Wysoczynski M; Reca R; Ratajczak J; Kucia M; Shirvaikar N; Honczarenko M; Mills M; Wanzeck J; Janowska-Wieczorek A; Ratajczak MZ
Blood; 2005 Jan; 105(1):40-8. PubMed ID: 15328152
[TBL] [Abstract][Full Text] [Related]
14. Targeting the cross-talk between Urokinase receptor and Formyl peptide receptor type 1 to prevent invasion and trans-endothelial migration of melanoma cells.
Ragone C; Minopoli M; Ingangi V; Botti G; Fratangelo F; Pessi A; Stoppelli MP; Ascierto PA; Ciliberto G; Motti ML; Carriero MV
J Exp Clin Cancer Res; 2017 Dec; 36(1):180. PubMed ID: 29216889
[TBL] [Abstract][Full Text] [Related]
15. Direct evidence of the importance of vitronectin and its interaction with the urokinase receptor in tumor growth.
Pirazzoli V; Ferraris GM; Sidenius N
Blood; 2013 Mar; 121(12):2316-23. PubMed ID: 23327926
[TBL] [Abstract][Full Text] [Related]
16. Plasminogen activator inhibitor-1 detaches cells from extracellular matrices by inactivating integrins.
Czekay RP; Aertgeerts K; Curriden SA; Loskutoff DJ
J Cell Biol; 2003 Mar; 160(5):781-91. PubMed ID: 12615913
[TBL] [Abstract][Full Text] [Related]
17. Regulation of alpha5beta1 integrin conformation and function by urokinase receptor binding.
Wei Y; Czekay RP; Robillard L; Kugler MC; Zhang F; Kim KK; Xiong JP; Humphries MJ; Chapman HA
J Cell Biol; 2005 Jan; 168(3):501-11. PubMed ID: 15684035
[TBL] [Abstract][Full Text] [Related]
18. The cleavage of the urokinase receptor regulates its multiple functions.
Montuori N; Carriero MV; Salzano S; Rossi G; Ragno P
J Biol Chem; 2002 Dec; 277(49):46932-9. PubMed ID: 12297505
[TBL] [Abstract][Full Text] [Related]
19. Heat shock proteins HSP70 and MRJ cooperatively regulate cell adhesion and migration through urokinase receptor.
Lin Y; Peng N; Zhuang H; Zhang D; Wang Y; Hua ZC
BMC Cancer; 2014 Aug; 14():639. PubMed ID: 25175595
[TBL] [Abstract][Full Text] [Related]
20. Domain 2 of the urokinase receptor contains an integrin-interacting epitope with intrinsic signaling activity: generation of a new integrin inhibitor.
Degryse B; Resnati M; Czekay RP; Loskutoff DJ; Blasi F
J Biol Chem; 2005 Jul; 280(26):24792-803. PubMed ID: 15863511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
